Market Tracker

09/02 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

During the Trading Day
101.62 +3.72 / +3.80%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
101.62 0.00 / 0.00%
 
Volume: 13.7K

Today’s Trading

Previous close97.90
Today’s open99.77
Day’s range95.52 - 101.81
Volume759,623
Average volume (3 months)757,471
Market cap$8.3B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+32.55%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.07

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.94+2.70%
ISISIsis Pharmaceuticals...+3.00+6.15%
ICLRICON PLC+1.13+1.51%
PRXLPAREXEL Internationa...+0.94+1.48%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts